Charlotte, NC 的 過重 臨床試驗
15 項針對 過重 的研究正在 Charlotte（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
招募中3 期
- Novant Health Heart and Vascular Institute, Charlotte
- Monroe Biomedical Research, Monroe · 距離 24 英里
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
招募中2 期
- Monroe Biomedical Research /ID# 282009, Monroe · 距離 24 英里
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
招募中3 期
- Monroe Biomedical Research, Monroe · 距離 24 英里
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
招募中2 期
- Monroe Biomedical Research, Monroe · 距離 24 英里
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
招募中3 期
- Monroe Biomedical Research, Monroe · 距離 24 英里
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
招募中3 期
- Research Site, Monroe · 距離 24 英里
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Charlotte
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, Charlotte
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
招募中3 期歡迎健康志工
- ACCOMPLISH-2 Research Site, Charlotte
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
招募中2 期
- Monroe Biomedical Research, Monroe · 距離 24 英里
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
招募中4 期
- Onsite Clinical Solutions - Huntersville, Huntersville · 距離 13 英里
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
招募中3 期
- Kailera Clinical Site, Monroe · 距離 24 英里
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
招募中3 期
- ACCOMPLISH-1 Research Site, Charlotte
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
招募中1 期
- Monroe Biomedical Research, LLC, Monroe · 距離 24 英里
A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
招募中2 期
- Monroe Biomedical Research, Monroe · 距離 24 英里
其他城市的 過重 試驗
- San Antonio, TX34 項研究
- Houston, TX33 項研究
- Chicago, IL29 項研究
- Orlando, FL27 項研究
- Las Vegas, NV23 項研究
- Miami, FL23 項研究
- Dallas, TX20 項研究
- Atlanta, GA20 項研究
- New York City, NY19 項研究
- Jacksonville, FL19 項研究
- Washington, DC19 項研究
- Austin, TX18 項研究
Charlotte 的其他研究
- 癌症（所有類型）27 項研究
- 乳癌22 項研究
- 多發性骨髓瘤21 項研究
- 非小細胞肺癌19 項研究
- 急性髓系白血病16 項研究
- 肥胖症16 項研究
- 大腸直腸癌13 項研究
- 卵巢癌12 項研究
- 心臟衰竭11 項研究
- 轉移性癌症11 項研究
- 頭頸部鱗狀細胞癌10 項研究
- 慢性阻塞性肺病9 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。